FULGENT GENETICS, INC. Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities
FULGENT GENETICS, INC. (FLGT) reported Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities of $19.10 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities · last filed 2024-02-28
- FULGENT GENETICS, INC. proceeds from maturities, prepayments and calls of held-to-maturity securities for fiscal 2022 was $19.10M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities 12 month |
|---|---|
| 2022-12-31 | $19.10M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |